Skip to content

TriVascular Technologies, Inc.

Delisted

CIK 1432732fmd_1RD5WE4DH1D6X2VKQK9JE4M56FManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2015, 12 periods

Income Statement · Annual · Millions · USD
Line itemFY2012FY2013FY2014
Total revenues52032
Cost of revenue91214
Gross profit(4)818
Research and development121316
Selling, general and administrative193852
Total operating expenses315268
Operating income(34)(44)(50)
Interest expense468
Other non-operating income (expense)(1)01
Income before taxes(43)(50)(57)
Income tax expense000
Net income from continuing operations(43)(50)(57)
Net income(43)(50)(57)